BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 24/06/2021

FDA Hosts Public Workshop to Discuss PML Clinical Trial Designs

The FDA is hosting a public workshop to discuss the challenges and design considerations for developing therapeutic products for progressive multifocal leukoencephalopathy (PML), a rare and serious brain disease.

Source: Federal Register — Food and Drug AdministrationOpen original release →